Citrus peel · Limonene
Limonene contributes to citrus aromas and occurs in many other plants. Their full profiles contain different mixtures of compounds.
Composition and context
A worked example of approaching a familiar profile from the strains you already have — terpenes first, then direction. It shows a reasoning path, not a formula, a dose or a promise of the same experience.

Limonene contributes to citrus aromas and occurs in many other plants. Their full profiles contain different mixtures of compounds.
Pine and rosemary both contain pinene. Their other compounds contribute to the differences in how they smell.
Lavender contains linalool and is used in fragrance and aromatherapy. Studies of the whole oil don’t necessarily tell us what linalool does on its own or in another plant.
Compare the source, the full mixture and how it’s used. Smelling a herb, eating a food and using a cannabis product involve different exposures, even when some of the same terpenes are present.
Learn the compounds in the Field GuideThis example uses a familiar strain as a reference to demonstrate how TerpeneU examines available products, their terpene compositions, and how they might work together in a blend.
In actual use, TerpeneU starts with the individual: their current state, needs, desired direction, previous responses, and available toolkit. It then examines possible combinations, using terpene composition as the primary organizing framework while also considering genetics, cannabinoid profiles, cultivation differences, and individual experience.
The objective is not to recreate a particular strain. It is to develop a blend direction suited to the person and the situation.
Here, Northern Lights provides a recognizable reference for showing how that methodology works. Strain reconstruction is an accessible demonstration of the methodology.
Step 1 · Target and proposed blend
Target reference: Ma Ku Northern Lights flower, Bia Diagnostics report C231204AJ, December 2023. This specific sample was myrcene-led. Compare it with the three separately tested components below. SAMPLE-SPECIFIC
Target
Ma Ku · Bia Diagnostics · C231204AJ · December 2023
This specific flower sample was myrcene-led.
Blend · 60%
Green Fish Family Farm · Onward Analytics · VT21561 · June 2025
Lot #19 · terpene test #70354.
Blend · 30%
Glass House Brands · BelCosta Labs · BCL-240607-136 · June 2024
Batch H507BDR053024BULK.
Blend · 10%
VJ Farms · Keystone State Testing of New York · sample #15197 · May 2025
Report #58914. Filename/batch mismatch remains unresolved; ND is not zero.
The four tiers summarize selected analytes by relative abundance within each sample; they are display groupings, not laboratory classifications. Trace includes minor quantified entries or an explicit reporting limit. ND and <LOQ do not establish absence. Full values and qualifications are in View Chemical Matching Details below.
Step 2 · The available toolkit
Base, Support and Accent describe each component’s place in this illustrative blend. They are not fixed experiential roles for the strain names.
The selected assay contributes myrcene and caryophyllene alongside limonene, humulene and linalool.
The selected assay contributes additional myrcene and pinenes. These measurements do not establish clarity or stimulation.
The selected assay contributes caryophyllene and humulene. Its myrcene, linalool and pinenes are ND at a 0.1000% LOQ.
Step 3 · Terpene-first reconstruction direction
Proposed illustrative blend · 60 / 30 / 10 by flower mass.
Working direction: body settling with room for mental engagement and emotional warmth. Activation, physical heaviness and sedation remain separate observations. Settling does not establish that clarity is preserved or that sleepiness will follow. This integrated readout is a hypothesis for observation, not an outcome measured in this blend.
Illustrative observation bands — subject to actual product chemistry and individual experience.
Bands mark broad possibilities to observe, not measured intensities, probabilities or forecasts. The laboratory reports did not measure these experiences.
Illustrative observation band: Moderate to Notable. Not a measured intensity or probability. A moderate to notable settling direction is the illustrative aim. Whether tension eases needs to be observed; the terpene match does not establish it.
Illustrative observation band: Light to Notable. Not a measured intensity or probability. Clarity may remain accessible or may soften. Pinene content does not guarantee focus or protect against THC-related impairment.
Illustrative observation band: Light to Notable. Not a measured intensity or probability. Comfort, openness or warmth are possible experiences to notice, not effects demonstrated by these laboratory reports.
Illustrative observation band: Faint to Moderate. Not a measured intensity or probability. Activation is not the intended emphasis of this example. Mental lift, restlessness or anxiety can still occur; low terpinolene does not rule them out.
Illustrative observation band: Light to Notable. Not a measured intensity or probability. Heaviness may develop alongside settling or may stay limited. Track it separately from relaxation and from the ability to stay mentally engaged.
Illustrative observation band: Light to Pronounced. Not a measured intensity or probability. Drowsiness is possible and may be substantial for some people. This broad band is not a probability estimate; THC exposure, tolerance, timing and individual response matter.
In the selected samples, the candidate matches myrcene and caryophyllene reasonably well but falls short on humulene, linalool and some limonene. That chemical overlap does not establish an equivalent experience.
Reported concentrations are percent of tested flower mass, as printed in each certificate. Derived blend = 0.60 × Gelato 41 + 0.30 × Blue Dream + 0.10 × GG4. This assumes additive component mass fractions before consumption.
| Analyte | Northern Lights | Gelato 41 | Blue Dream | GG4 | Calculated blend | Difference from target |
|---|---|---|---|---|---|---|
| β-Myrcene | 0.504 | 0.4205 | 0.92922 | ND (<0.1000) | [0.531066, 0.541066) | +0.027066 to <+0.037066 |
| β-Caryophyllene | 0.467 | 0.4647 | 0.28436 | 1.425 | 0.506628 | +0.039628 |
| Limonene | 0.244 | 0.2779 | 0.10931 | 0.1274 | 0.212273 | −0.031727 |
| α-Humulene | 0.243 | 0.1309 | 0.09700 | 0.4150 | 0.149140 | −0.093860 |
| Linalool | 0.216 | 0.102 | 0.07395 | ND (<0.1000) | [0.083385, 0.093385) | −0.132615 to <−0.122615 |
| α-Pinene | 0.174 | 0.0309 | 0.40317 | ND (<0.1000) | [0.139491, 0.149491) | −0.034509 to <−0.024509 |
| β-Pinene | 0.116 | 0.0433 | 0.18537 | ND (<0.1000) | [0.081591, 0.091591) | −0.034409 to <−0.024409 |
| Terpinolene | 0.026 | 0.0041 | <0.013809 | ND (<0.1000) | [0.002460, 0.016603) | −0.023540 to <−0.009397 |
| Total terpenes (as reported) | 2.114 | 1.6498 | 2.10137 | 2.727 | 1.892991 | −0.221009 |
Example: β-caryophyllene = 0.60 × 0.4647 + 0.30 × 0.28436 + 0.10 × 1.425 = 0.506628%.
Illustrative educational comparison only. The 60 / 30 / 10 ratios are hypothetical flower-mass proportions, not an optimized consumption formula. This is not a validated reconstruction, measured experiential outcome or clinical prediction. The laboratory reports measure chemistry, not human effects.
Step 4 · The TerpeneU rollout
Subject to actual product chemistry and individual experience.
General observation sequence only. No controlled study of this blend establishes an onset, duration or effect sequence.
Observation · 1
Notice the starting shift in body tension, clarity, emotional tone and activation. Settling, stimulation or unease are possibilities to record, not an assumed onset sequence.
Observation · 2
Observe whether body settling coexists with mental engagement and emotional warmth. Distinguish ease from physical heaviness, reduced clarity or emerging drowsiness.
Observation · 3
Record whether the direction eases, persists or becomes heavier or sleepier, along with any residual impairment. There is no fixed timing or guaranteed progression.
Products sold under the same cultivar name can vary with breeding, cultivation, curing and storage. This comparison uses four particular reported laboratory samples. It can’t establish genetic equivalence, matching effects or a consumption regimen.
For help recording your starting state and response, read State Mapping.
Read about State Mapping